A pilot open label trial of HIV therapy with d4T (stavudine), ddI (didanosine), nelfinavir and hydroxyurea [hydroxycarbamide] in subjects with recent HIV infection
Latest Information Update: 18 Jan 2007
At a glance
- Drugs Didanosine (Primary) ; Hydroxycarbamide (Primary) ; Nelfinavir (Primary) ; Stavudine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 19 Dec 2006 Status change
- 22 Oct 2005 New trial record.